Azithromycin add-on therapy reduces airway inflammation and extracellular DNA: An AMAZES sub-study.

J. Simpson (Newcastle, Australia), D. Barker (Newcastle, Australia), I. Yang (Brisbane, Australia), J. Upham (Brisbane, Australia), P. Reynolds (Adelaide, Australia), S. Hodge (Adelaide, Australia), A. James (Perth, Australia), C. Jenkins (Sydney, Australia), M. Peters (Sydney, Australia), G. Marks (Sydney, Australia), M. Baraket (Sydney, Australia), P. Gibson (Newcastle, Australia)

Source: International Congress 2019 – Novel findings from asthma clinical trials
Session: Novel findings from asthma clinical trials
Session type: Oral Presentation
Number: 5338

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Simpson (Newcastle, Australia), D. Barker (Newcastle, Australia), I. Yang (Brisbane, Australia), J. Upham (Brisbane, Australia), P. Reynolds (Adelaide, Australia), S. Hodge (Adelaide, Australia), A. James (Perth, Australia), C. Jenkins (Sydney, Australia), M. Peters (Sydney, Australia), G. Marks (Sydney, Australia), M. Baraket (Sydney, Australia), P. Gibson (Newcastle, Australia). Azithromycin add-on therapy reduces airway inflammation and extracellular DNA: An AMAZES sub-study.. 5338

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: